Nu khng c vn g xy ra sau vi gi, bn c th tip tc s dng
Tirzepatide also targets a second receptor (GIP), which may produce slightly greater weight loss in some patients
A large cohort study found the gastroparesis and pancreatitis risk figures cited above among patients using GLP-1 agonists specifically for weight loss, not diabetes
In the following sections, we will dive deeper into what semaglutide is, how it works, and how it could specifically benefit people with MS
Gastrointestinal Adverse Reactions In a pool of Study 1 and 2, gastrointestinal adverse reactions occurred more frequently among patients receiving ZEPBOUND (5 mg 56%, 10 mg 56%, 15 mg 56%) than placebo (30%)
10 pounds down in the first month!" "its been a smooth process" "Ive tried every diet under the sun, but this is the ONLY thing thats ever worked